Lipid-Modified Aminoglycoside Derivatives for In Vivo siRNA Delivery

被引：34

作者：

Zhang, Yunlong ^{[1
,2
,3
]}

Pelet, Jeisa M. ^{[1
,3
]}

Heller, Daniel A. ^{[2
,5
]}

Dong, Yizhou ^{[3
]}

Chen, Delai ^{[1
]}

Gu, Zhen ^{[1
,3
]}

Joseph, Brian J. ^{[2
,5
]}

Wallas, Jasmine ^{[5
]}

Anderson, Daniel G. ^{[1
,2
,3
,4
]}

机构：

[1] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA

[2] MIT, Dept Chem Engn, Cambridge, MA 02139 USA

[3] Childrens Hosp Boston, Dept Anesthesiol, Boston, MA 02115 USA

[4] MIT, Inst Med Engn & Sci, Cambridge, MA 02139 USA

[5] Mem Sloan Kettering Canc Ctr, Mol Pharmacol & Chem Program, New York, NY 10065 USA

来源：

ADVANCED MATERIALS | 2013年 / 25卷 / 33期

关键词：

siRNA; drug delivery; nanoparticle; gene knockdown; aminoglycoside; DOUBLE-STRANDED-RNA; CATIONIC LIPIDS; NANOPARTICLES; INTERFERENCE; EFFICIENT; POTENT; VECTORS;

D O I：

10.1002/adma.201301917

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

Rationally designed siRNA delivery materials that are enabled by lipid-modified aminoglycosides are demonstrated. Leading materials identified are able to self-assemble with siRNA into well-defined nanoparticles and induce efficient gene knockdown both in vitro and in vivo. Histology studies and liver function tests reveal that no apparent toxicity is caused by these nanoparticles at doses over two orders of magnitude. Copyright © 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

引用

页码：4641 / 4645

页数：5

共 43 条

[21] Action and Reaction: The Biological Response to siRNA and Its Delivery Vehicles
Kanasty, Rosemary L.
Whitehead, Kathryn A.
Vegas, Arturo J.
Anderson, Daniel G.
[J]. MOLECULAR THERAPY, 2012, 20 (03) : 513 - 524
[22] Neomycin-acridine conjugate: A potent inhibitor of Rev-RRE binding
Kirk, SR
Luedtke, NW
Tor, Y
[J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2000, 122 (05) : 980 - 981
[23] Biocompatibility and drug delivery systems
Kohane, Daniel S.
Langer, Robert
[J]. CHEMICAL SCIENCE, 2010, 1 (04) : 441 - 446
[24] Cationic Lipid-Coated Gold Nanoparticles as Efficient and Non-Cytotoxic Intracellular siRNA Delivery Vehicles
Kong, Won Ho
Bae, Ki Hyun
Jo, Sung Duk
Kim, Jee Seon
Park, Tae Gwan
[J]. PHARMACEUTICAL RESEARCH, 2012, 29 (02) : 362 - 374
[25] Lee H, 2012, NAT NANOTECHNOL, V7, P389, DOI [10.1038/nnano.2012.73, 10.1038/NNANO.2012.73]
[26] Lee JB, 2012, NAT MATER, V11, P316, DOI [10.1038/NMAT3253, 10.1038/nmat3253]
[27] Therapeutic siRNA silencing in inflammatory monocytes in mice
Leuschner, Florian
Dutta, Partha
Gorbatov, Rostic
Novobrantseva, Tatiana I.
Donahoe, Jessica S.
Courties, Gabriel
Lee, Kang Mi
Kim, James I.
Markmann, James F.
Marinelli, Brett
Panizzi, Peter
Lee, Won Woo
Iwamoto, Yoshiko
Milstein, Stuart
Epstein-Barash, Hila
Cantley, William
Wong, Jamie
Cortez-Retamozo, Virna
Newton, Andita
Love, Kevin
Libby, Peter
Pittet, Mikael J.
Swirski, Filip K.
Koteliansky, Victor
Langer, Robert
Weissleder, Ralph
Anderson, Daniel G.
Nahrendorf, Matthias
[J]. NATURE BIOTECHNOLOGY, 2011, 29 (11) : 1005 - U73
[28] Lipid-like materials for low-dose, in vivo gene silencing
Love, Kevin T.
Mahon, Kerry P.
Levins, Christopher G.
Whitehead, Kathryn A.
Querbes, William
Dorkin, J. Robert
Qin, June
Cantley, William
Qin, Liu Liang
Racie, Timothy
Frank-Kamenetsky, Maria
Yip, Ka Ning
Alvarez, Rene
Sah, Dinah W. Y.
de Fougerolles, Antonin
Fitzgerald, Kevin
Koteliansky, Victor
Akinc, Akin
Langer, Robert
Anderson, Daniel G.
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (05) : 1864 - 1869
[29] Five Years of siRNA Delivery: Spotlight on Gold Nanoparticles
Lytton-Jean, Abigail K. R.
Langer, Robert
Anderson, Daniel G.
[J]. SMALL, 2011, 7 (14) : 1932 - 1937
[30] Combinatorial Approach to Determine Functional Group Effects on Lipidoid-Mediated siRNA Delivery
Mahon, Kerry P.
Love, Kevin T.
Whitehead, Kathryn A.
Qin, June
Akinc, Akin
Leshchiner, Elizaveta
Leshchiner, Ignaty
Langer, Robert
Anderson, Daniel G.
[J]. BIOCONJUGATE CHEMISTRY, 2010, 21 (08) : 1448 - 1454

← 1 2 3 4 5 →